Analytical Data
-
Gene name
enoA
- Application
-
Alternative Names
2-phospho-D-glycerate hydro-lyase 2-phosphoglycerate dehydratase Allergen: Asp f 22
-
Species
Neosartorya fumigata
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96X30
-
Expression Region
2-438aa
-
Molecular Weight
51.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Enolase A (enoA) is a key glycolytic enzyme that plays a crucial role in cellular metabolism by catalyzing the conversion of 2-phosphoglycerate to phosphoenolpyruvate. Its involvement in various metabolic pathways makes it a significant molecule for studying energy production and regulation in cells. In recent years, research has increasingly focused on the expression and characterization of recombinant enoA proteins due to their potential applications in biotechnology and medicine. Recombinant enoA can be utilized in enzyme replacement therapies, metabolic engineering, and vaccine development, particularly in the context of pathogenic organisms where eneA plays a role in virulence. Furthermore, the study of enoA's structure and function can provide insights into its regulatory mechanisms and interaction with other cellular components. Advances in recombinant DNA technology and protein expression systems have facilitated the production of enoA in microbial hosts, allowing for detailed biochemical analysis and potential therapeutic uses. Understanding the biology of enoA can reveal new strategies for targeting metabolic pathways in diseases such as cancer and metabolic disorders. Overall, the recombinant enoA protein represents a valuable tool in both fundamental and applied research, highlighting the interconnectedness of metabolic enzymes and their potential in innovative therapeutic strategies.
